Flocoumafen structure
|
Common Name | Flocoumafen | ||
|---|---|---|---|---|
| CAS Number | 90035-08-8 | Molecular Weight | 542.544 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 672.4±55.0 °C at 760 mmHg | |
| Molecular Formula | C33H25F3O4 | Melting Point | 181-191 (cis-isomer). 163-166 (trans- isomer)ºC | |
| MSDS | USA | Flash Point | 360.5±31.5 °C | |
| Symbol |
GHS06, GHS08, GHS09 |
Signal Word | Danger | |
Use of FlocoumafenFlocoumafen (WL 108366), a second-generation anticoagulant rodenticide (ARs), belongs to the family of vitamin K antagonist (VKA) molecules[1][2]. |
| Name | flocoumafen |
|---|---|
| Synonym | More Synonyms |
| Description | Flocoumafen (WL 108366), a second-generation anticoagulant rodenticide (ARs), belongs to the family of vitamin K antagonist (VKA) molecules[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 672.4±55.0 °C at 760 mmHg |
| Melting Point | 181-191 (cis-isomer). 163-166 (trans- isomer)ºC |
| Molecular Formula | C33H25F3O4 |
| Molecular Weight | 542.544 |
| Flash Point | 360.5±31.5 °C |
| Exact Mass | 542.170471 |
| PSA | 59.67000 |
| LogP | 8.77 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.629 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06, GHS08, GHS09 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300-H310-H330-H372-H410 |
| Precautionary Statements | P273-P314-P501 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T+: Very toxic;N: Dangerous for the environment; |
| Risk Phrases | 26/27/28-48/23/24/25-50/53 |
| Safety Phrases | 28-36/37/39-45-60-61 |
| RIDADR | UN 3027 |
| RTECS | DJ3100300 |
| Packaging Group | I |
| Hazard Class | 6.1(a) |
|
Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using LC-MS/MS.
Forensic Sci. Int. 243 , 35-43, (2014) The aim of this study was to develop an LC-MS/MS based screening technique that covers a broad range of acidic and neutral drugs and poisons by combining a small sample volume and efficient extraction... |
|
|
Acquired coagulopathy caused by intoxication with the superwarfarin-type anticoagulant rodenticide flocoumafen.
Eur. J. Haematol. 86(2) , 173-5, (2011) A 28 year-old heretofore healthy woman was transferred to our hospital with a two-month history of recurring episodes of bleeding. Administration of vitamin K and prothrombin complex concentrates in t... |
|
|
Metabolic and toxicological studies on the anticoagulant rodenticide, flocoumafen.
Arch. Toxicol. Suppl. 14 , 160-5, (1991)
|
| 4-Hydroxy-3-[1,2,3,4-tetrahydro-3-[4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1-naphthalenyl]-2H-1-benzopyran-2-one |
| Storm |
| stratgem |
| Stratagen |
| Storm(rodenticide) |
| 4-Hydroxy-3-[3-(4-{[4-(trifluoromethyl)benzyl]oxy}phenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2H-chromen-2-one |
| 4-Hydroxy-3-[3-(4-{[4-(trifluormethyl)benzyl]oxy}phenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]-2H-chromen-2-on |
| FLOCUMAFEN |
| 4-Hydroxy-3-[3-(4-{[4-(trifluoromethyl)benzyl]oxy}phenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]-2H-chromen-2-one |
| aphthyl)coumarin |
| 1RS,3SR)-1,2,3,4-tetrahydro-3-[4-(4-trifluoromethylbenzyloxy)phenyl]-1-naphthyl]coumarin |
| 2H-1-Benzopyran-2-one, 4-hydroxy-3-[1,2,3,4-tetrahydro-3-[4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1-naphthalenyl]- |
| 4-Hydroxy-3-[3-(4-{[4-(trifluormethyl)benzyl]oxy}phenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2H-chromen-2-on |
| Flocoumafen |
| EINECS 421-960-0 |
| 4-hydroxy-3-[(1Ξ,3Ξ)-3-(4-{[4-(trifluoromethyl)phenyl]methoxy}phenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2H-1-benzopyran-2-one |
| 4-hydroxy-3-[(1RS,3RS |
| MFCD01662724 |